A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis
Cardiac amyloidosis, caused by deposition of immunoglobulin light chains (AL) or transthyretin (ATTR), carries a poor prognosis. Established risk scores for amyloidosis may not predict outcomes in those patients who develop advanced heart failure and who are potential candidates for heart transplant...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
Clinical research in cardiology
Year: 2020, Jahrgang: 109, Heft: 6, Pages: 700-713 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-019-01559-y |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-019-01559-y |
| Verfasserangaben: | Michael M. Kreusser, Martin J. Volz, Benjamin Knop, Philipp Ehlermann, Bastian Schmack, Arjang Ruhparwar, Ute Hegenbart, Stefan O. Schönland, Hugo A. Katus, Philip W. Raake |
| Zusammenfassung: | Cardiac amyloidosis, caused by deposition of immunoglobulin light chains (AL) or transthyretin (ATTR), carries a poor prognosis. Established risk scores for amyloidosis may not predict outcomes in those patients who develop advanced heart failure and who are potential candidates for heart transplantation. Here, we aimed to identify predictive parameters for patients with severe heart failure due to amyloidosis. |
|---|---|
| Beschreibung: | Gesehen am 17.11.2020 Published online: 19 October 2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-019-01559-y |